Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02202811 · ClinicalTrials.gov registry record · NA
Circadian Rhythms and Cardiovascular Risk
A NA study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- NA
- Development phase
- 39
- Enrollment target
NCT02202811 is a NA study that has completed, run by Oregon Health and Science University. The registered enrollment target is 39 participants.
The verdict
NCT02202811, a NA study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
Study Summary
The purpose of this study is to understand how behaviors and the effects of the body's internal clock (called the circadian pacemaker) affect the control of the heart and blood pressure. People with Obstructive Sleep Apnea (OSA) are hypothesized to have altered circadian amplitudes in certain key indices of cardiovascular (CV) and an abnormally advanced circadian phase in some of the same key indices of CV risk. The investigators hypothesize that such changes, taken together, may explain the different timing of heart attack and sudden cardiac death in OSA.
Interventions
- BEHAVIORAL Forced Desynchrony
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2014-08 |
| Est. Completion | 2020-03-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02202811
The ClinicalTrials.gov registry entry for NCT02202811 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Forced Desynchrony is the first listed.
NCT02202811 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02202811 about?
NCT02202811 is a clinical study titled "Circadian Rhythms and Cardiovascular Risk". The purpose of this study is to understand how behaviors and the effects of the body's internal clock (called the circadian pacemaker) affect the control of the heart and blood pressure. People with Obstructive Sleep Apnea (OSA) are hypothesized to have altered circadian amplitudes in certain key i...
What is the current status of trial NCT02202811?
This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2014-08. Estimated completion is 2020-03-09.
What interventions are being tested in trial NCT02202811?
The interventions under investigation include: Forced Desynchrony (BEHAVIORAL).
Who is sponsoring clinical trial NCT02202811?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.